ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Anormed Ord (MM)

Anormed Ord (MM) (ANOR)

0.00
0.00
(0.00%)
At close: 09 January 8:00AM
0.00
0.00
( 0.00% )

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
-
Bid
-
Offer
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

ANOR Latest News

Genzyme Completes Tender Offer for Outstanding Shares of AnorMED

Acquisition to Strengthen Transplant and Oncology Businesses CAMBRIDGE, Mass. and VANCOUVER, B.C., Nov. 7 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and AnorMED Inc. (Nasdaq:...

Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review

CAMBRIDGE, Mass. and VANCOUVER, B.C., Nov. 7 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and AnorMED Inc. (Nasdaq: ANOR; TSX: AOM) announced today the expiration of the waiting...

AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events

AnorMED Board Recommends Shareholders Accept Genzyme Offer LANGLEY, BC, Nov. 3 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (NASDAQ:ANOR; TSX:AOM) today released its...

Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer

SEATTLE, Oct. 26 /PRNewswire/ -- Koronis Pharmaceuticals, Inc. today announced the appointment of Stephen Becker, M.D., as chief medical officer. Dr. Becker joins Koronis from AnorMED...

AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule

VANCOUVER, Oct. 23 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) today announced that it has completed enrollment in the second pivotal Phase III clinical trial evaluating its...

AnorMED and Genzyme reach agreement on acquisition

Genzyme to Gain Late-Stage Transplantation Product Candidate VANCOUVER, BC, and CAMBRIDGE, MA, Oct. 17 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and AnorMED Inc. (Nasdaq: ANOR;...

AnorMED has determined Genzyme's offer is a 'superior proposal'

Millennium has the right to match Genzyme's 'superior proposal' VANCOUVER, Oct. 11 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or "the Company") (NASDAQ:ANOR; TSX:AOM) announced that it...

AnorMED has determined Genzyme's offer is a 'superior proposal'

Millennium has the right to match Genzyme's 'superior proposal' VANCOUVER, Oct. 11 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or "the Company") (NASDAQ:ANOR; TSX:AOM) announced that it...

AnorMED announces receipt of proposal from Genzyme Corporation

VANCOUVER, Oct. 10 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) announced today that it has received a proposal from Genzyme Corporation (NASDAQ:GENZ), acting through its wholly...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ANOR - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is US$ 0.00
What is the 1 year trading range for share price?
has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCEAlternus Clean Energy Inc
US$ 1.07
(64.59%)
2.56M
ACXPAcurx Pharmaceuticals Inc
US$ 0.9974
(32.81%)
335.42k
CHNRChina Natural Resources Inc
US$ 0.96
(28.50%)
4.64M
STAIScanTech AI Systems Inc
US$ 2.76
(26.61%)
2.29M
KAVLKaival Brands Innovations Group Inc
US$ 1.16
(16.00%)
3.45M
XXII22nd Century Group Inc
US$ 6.13
(-24.32%)
452.31k
SILOSilo Pharma Inc
US$ 1.37
(-19.88%)
858.99k
AVDLAvadel Pharmaceuticals PLC
US$ 8.60
(-19.55%)
171.27k
IMGCIMG Inc
US$ 0.69015
(-13.92%)
250.74k
SYTASiyata Mobile Inc
US$ 7.72
(-11.57%)
54.29k
MBIOMustang Bio Inc
US$ 0.25
(12.41%)
14.82M
XTIAXTI Aerospace Inc
US$ 0.05
(-0.99%)
6.46M
CHNRChina Natural Resources Inc
US$ 0.9725
(30.17%)
4.64M
KAVLKaival Brands Innovations Group Inc
US$ 1.16
(16.00%)
3.45M
ESGEiShares Inc iShares ESG Aware MSCI EM ETF
US$ 33.47
(0.00%)
3.06M

Discussion

View Full Feed
Golfbum22 Golfbum22 5 minutes ago
how many persons who just can't shut their negative mouths about the GSE's

-failin' whalen

-cat man do nothing

-who else?

go new admin and

GO FnF

end this theft and bogus conservatorship already in the first 10
FNMA
Law of Averages Law of Averages 5 minutes ago
Yes but this had a long Inverted Hammer candle at the close this should continue to move upwards. Also ALLR is making higher lows and higher highs. 📈
ALLR
Paulie Pennies Paulie Pennies 5 minutes ago
Close to 40 years trading and this should be multi pennies, those walls use to come down in seconds. Don't get it SMH 😎
ASII
djohn djohn 6 minutes ago
I know the area well and the fires are not near Avid.
CDMO
123tom 123tom 6 minutes ago
Let's adjust this, by looking in hindsight now at the 5 minute chart. From the immediate opening plunge down, you can see where the moves stopped, paused, and sold down more to the next targets. And then slid sideways somewhere , that's a marker zone to configure, to redraw the chart, where to adju
AVXL
BigBadWolf BigBadWolf 6 minutes ago
$ASII @JimBnReamed painfully it seems he just can’t get over his failures & losses.
now back to Happy Hour by the sea for me

but obvious enough for all to see :-D
ASII
fliper fliper 6 minutes ago
just in case it would bounce with average down traders. looks like none event tho
TheRealMrPirate TheRealMrPirate 6 minutes ago
Formerly #09072Q106 - FKA bioaq
False statement - Bankruptcy was not dismissed.
The proceedings changed from Chapter 11 bankruptcy over to Chapter 15 bankruptcy.
You already know that though which only means one thing, you're lying yet "AGAIN". Tsk
gdog gdog 6 minutes ago
01-02 DBRG $ 11.28 + .40 share
halbroke1 halbroke1 6 minutes ago
UMAV $$$..Will be a Monster..If The Contracts in Value are Estimated at 1.5 Billion+, This Should go to $2.00+ at Least...Opinions..Thanks...What a Hidden Gem..
UMAV
Filterthenoise Filterthenoise 7 minutes ago
Shareholders AKA 'trolls & hypocrites' to exposed FUD dancing in desperation🎅
RNVA
ThunderousSeer8 ThunderousSeer8 7 minutes ago
I've known that for about a month. There was a time recently where an account asked a question and within a minute Crowin replied with an extensive reply that unless previously prepared would have taken too long. It's insane
RDAR
researcher59 researcher59 7 minutes ago
Reminder - Market is closed tomorrow for Jimmy Carter's funeral.
BottomBounce BottomBounce 7 minutes ago
Ballard Power Systems Inc. engages in the design, development, manufacture, sale, and service of proton exchange membrane (PEM) fuel cell products. The company offers its products for power product comprising for bus, truck, rail, marine, stationary, and emerging market, such as material handling, o
BLDP
KILLAZILLA KILLAZILLA 8 minutes ago
4m. But, what's another $500 anyhow
WDLF
diamondguru-one diamondguru-one 8 minutes ago
SOMETHING HUGE is in the WORKS....BIG MONEY buying as much as they can the last several days.......

BUYOUT ????
PARTNER ????
HUGE CONTACTS ??????

I would LOVE to see T-Moblie the one BUYING up SYTA shares and offer for every one share of SYTA for ONE SHARE
SYTA
DesertDrifter DesertDrifter 8 minutes ago
the regs requiring 200% of profits be paid to the feds to fight climate change

that one could certainly use a link. As a supposed accountant, maybe you can explain how 200% of profits would work. Once you reach 100% of profits, then there are no more profits, eh?
gdog gdog 8 minutes ago
01-06 TU S $ 14.00 + .44 share
moneyhoney69 moneyhoney69 8 minutes ago
Exactly
CGRA
RichieBoy RichieBoy 9 minutes ago
That doesn't answer the long's question.
AFFU
Number sleven Number sleven 9 minutes ago
JRoon, Every lipid modifying agent is listed under the heading of cardiovascular medications.
Sleven,
AMRN
thesaud thesaud 9 minutes ago
I like the price at the end of the year. I don't like seeing the price over the next few months! Those are some big numbers down the road though. I think alot of holders will sell in the next few months. I'm holding through this year, but it will be painful to watch like it has been this week.
PLTR
Stock_Barber Stock_Barber 9 minutes ago
The company previously announced 2 production deals, stock ran up, they dumped lots of shares, and the deals collapsed... logically because the product failure to work as promised/anticipated.

The company announces this latest "deal", and it is deja vu...

Will we ever h
WATT

Your Recent History

Delayed Upgrade Clock